Human & Experimental Toxicology · 2016 · 20 citations · 34 references
PharmacyEndocrinologyOncologyCancer PreventionOccupational ToxicologySteroid BiochemistryBiomarkers Of Genotoxic ExposureCancer BiomarkersCytotoxicity EvaluationGenotoxicity Risk AssessmentMicronucleus FormationOccupational CarcinogenesisAnabolic Androgenic SteroidsAnabolic-androgenic Steroid UseBiomarkers Of Cancer RiskCancer Risk AssessmentChromosomal Damage AssessmentCytokinesis-block Micronucleus AssayLymphocyte Micronucleus FrequencyPeripheral Blood Micronucleus Test
The use of anabolic androgenic steroids (AAS) has grown among practitioners of recreational bodybuilding, with significant contributions of designer steroids, aiming muscle hypertrophy in healthy subjects. The abusive use of AAS in general is associated with adverse effects; one of the most worrisome is cancer development. The aim of this study was to evaluate the effectiveness of the cytokinesis block micronucleus (CBMN) test in human lymphocytes in identifying risk groups for cancer development in users of AAS. Blood was collected from 15 AAS users bodybuilders (G1), 20 non-users bodybuilders (G2) and 20 non-users sedentary (G3). MN analysis was performed on a minimum of 1000 binucleated lymphocytes. The occurrence of MN was significantly higher ( p < 0.05) in individuals of G1 compared to G2 and G3. The results indicate the sensitivity of CBMN in human lymphocytes in the identification of chromosomal damage in consequence of AAS.
34
Cytokinesis-block micronucleus cytome assay
Michael Fenech · Nature Protocols · 2007 · 2K citations · Full text
Cytokinesis-Blocked Micronucleus Assay as a Novel Biomarker for Lung Cancer Risk
Randa El‐Zein, Matthew B. Schabath, Carol J. Etzel et al. · Cancer Research · 2006 · 180 citations · Full text
Pharmacy, Oncology, Toxicology +17
Does physical activity induce DNA damage?
Andreas Hartmann, U. Plappert, Klaus Raddata et al. · Mutagenesis · 1994 · 174 citations
Pharmacy, Cell Biology, Physiology +14